A
Live / Registered — Registered and renewed (as of 14 Nov 2025)
What this means for you
Registered since 02 Feb 2016. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 02 Feb 2026).
Record
- Serial number
- 86680447
- Registration number
- 4895581
- Mark type
- Design + words
- Filed
- 01 Jul 2015
- Published for opposition
- 17 Nov 2015
- Registered
- 02 Feb 2016
- Next maintenance due
- 02 Feb 2026
- Attorney of record
- Rebecca A. Liebowitz
Goods and services
- Class 005 — Pharmaceuticals: Nutraceuticals for the treatment of bloating, abdominal discomfort, constipation
Owner
- KBS Research, LLC, Dallas, TX, US
- KBS Research, LLC, Dallas, TX, US
- KBS Research, LLC, Dallas, TX, US
Prosecution history
- 14 Nov 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 14 Nov 2025 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 14 Nov 2025 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 14 Nov 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 29 Jul 2025 — TEAS SECTION 8 & 9 RECEIVED
- 02 Feb 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 03 Mar 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 03 Mar 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 03 Mar 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 03 Mar 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 03 Mar 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 21 May 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 21 May 2022 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 10 May 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 18 Nov 2021 — TEAS SECTION 8 & 15 RECEIVED